FealtySign in
Promise-keeping streakStreak endedguidance & buyback

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

(CRL)

CIK 1100682 · SEC filings only

Not yet gradedBuyback record
harness minimum not met
company entity
1 resolved promise

Not enough resolved promises to grade

1 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.

See Pro →

Credibility timeline

MISSED · Jul 31, 2019
20192019
Timeline as a list
  • Jul 31, 2019MISSED$1.3 billion
1 resolved buyback promise · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →
D+Guidance record
grade
company entity
26 resolved promises

Sector median (Industrial Applications and Services): B+ across 28 graded companies

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.

See Pro →

Guidance by basis

14 of 40 guidance figures that were graded or dropped for basis could not be graded on the same basis (35%). Guidance marked “not judged” is in neither number.

Guidance typeSaidGradedDroppedOther
Revenue · non-GAAPcannot be graded2011
Revenue · basis not stated3913026
EPS · GAAP2913016
EPS · non-GAAPcannot be graded3201319

Said counts every revenue and EPS guidance figure on record. Dropped counts figures whose period was reported but which have no comparable GAAP actual in SEC XBRL. Other covers open, superseded, withdrawn and otherwise unresolved figures. The coverage note below counts every figure shown but not graded, including figures whose period has not been reported, so it can be larger.

How the site-wide rate is measured

Compare across companies

Guidance shown, not graded (43)

We show what was said — with its source filing — but never score it. The line under each statement says why.

  1. eps guidance fy · Feb 14, 2024
    Non-GAAP EPS estimate $10.90 – $11.40
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  2. eps guidance fy · Nov 8, 2023
    Non-GAAP EPS estimate $10.50 – $10.70
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  3. revenue guidance fy · Aug 9, 2023
    Revenue growth, organic (1) 5.5% – 7.5%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  4. eps guidance fy · Aug 9, 2023
    Non-GAAP EPS estimate $10.30 – $10.90
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  5. revenue guidance fy · May 11, 2023
    Revenue growth, organic (1) 5.0% – 7.5%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  6. eps guidance fy · May 11, 2023
    Non-GAAP EPS estimate $9.90 – $10.90
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  7. revenue guidance fy · Feb 22, 2023
    Revenue growth, organic (1) 4.5% – 7.5%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  8. eps guidance fy · Feb 22, 2023
    Non-GAAP EPS estimate $9.70 – $10.90
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  9. eps guidance fy · Nov 2, 2022
    Non-GAAP EPS $10.80 – $10.95
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  10. eps guidance fy · Aug 3, 2022
    Non-GAAP EPS $10.70 – $10.95
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  11. eps guidance fy · May 4, 2022
    Non-GAAP EPS $11.50 – $11.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  12. eps guidance fy · Feb 16, 2022
    Non-GAAP EPS estimate $11.50 – $11.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  13. eps guidance fy · Nov 3, 2021
    Non-GAAP EPS estimate $10.20 – $10.30
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  14. revenue guidance fy · Nov 3, 2021
    Revenue growth, organic (2) 13.5% – 14.5%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  15. eps guidance fy · Aug 4, 2021
    Non-GAAP EPS estimate $10.10 – $10.35
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  16. revenue guidance fy · Aug 4, 2021
    Revenue growth, organic (2) 13% – 15%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  17. eps guidance fy · May 4, 2021
    Non-GAAP EPS estimate $9.75 – $10.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  18. eps guidance fy · Feb 17, 2021
    Non-GAAP EPS estimate $9.00 – $9.25
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  19. eps guidance fy · Aug 5, 2020
    Non-GAAP EPS estimate $7.05 – $7.35
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  20. eps guidance fy · May 7, 2020
    Non-GAAP EPS estimate $6.75 – $7.10
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  21. eps guidance fy · Feb 11, 2020
    Non-GAAP EPS estimate $7.45 – $7.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  22. eps guidance fy · Nov 6, 2019
    Non-GAAP EPS estimate $6.50 - $6.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  23. eps guidance fy · Jul 31, 2019
    Non-GAAP EPS estimate $6.45 - $6.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  24. revenue guidance fy · Jul 31, 2019
    Revenue growth, organic (2) 8.5% - 9.5%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  25. eps guidance fy · May 7, 2019
    $6.40 - $6.55
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  26. eps guidance fy · Nov 7, 2018
    $5.87 - $5.97
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  27. eps guidance fy · May 10, 2018
    $5.77 - $5.92
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  28. eps guidance fy · Nov 9, 2017
    $5.08 - $5.18
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  29. eps guidance fy · May 10, 2017
    $5.00 - $5.15
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  30. revenue guidance fy · Aug 3, 2016
    21% - 24.5%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  31. eps guidance fy · Aug 3, 2016
    $4.40 - $4.50
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  32. revenue guidance fy · Feb 10, 2016
    Revenue growth including WIL Research, constant currency 20% - 23.5%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  33. eps guidance fy · Feb 10, 2016
    Non-GAAP EPS estimate including WIL Research (1) $4.27 - $4.40
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  34. eps guidance fy · Feb 10, 2016
    Non-GAAP EPS estimate $4.07 - $4.17
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  35. revenue guidance fy · Nov 4, 2015
    We now expect revenue growth in a range from 9.5% to 10% in constant currency
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  36. eps guidance fy · Nov 4, 2015
    non-GAAP earnings per share in a range from $3.69 to $3.74
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  37. revenue guidance fy · Apr 30, 2015
    Revenue growth is now expected to be 6.5% to 8.0% on a constant-currency basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  38. eps guidance fy · Apr 30, 2015
    $3.55 - $3.65
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  39. eps guidance fy · Oct 29, 2014
    Non-GAAP EPS estimate $3.33 - $3.38
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  40. eps guidance fy · Oct 30, 2013
    Non-GAAP EPS estimate (1) $2.85 - $2.90
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  41. revenue guidance fy · May 2, 2013
    we continue to expect to achieve our 2013 guidance of 4% to 6% constant-currency sales growth
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  42. eps guidance fy · May 2, 2013
    non-GAAP earnings per share in a range between $2.80 and $2.90
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  43. eps guidance fy · Oct 30, 2012
    Non-GAAP EPS estimate $2.68 - $2.73
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗

Open promises (1) · 32 superseded

Open · revenue guidance q

Revenue growth, reported 9.0% – 11.0%

unresolved — no outcome on filereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue growth, reported 8% - 10%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue growth, reported 2.5% – 4.5%

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

GAAP EPS estimate $7.45 – $8.45

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue growth, reported 13.5% – 15.5%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue growth, reported 2.0% – 4.5%

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

$4.22-$4.37

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

GAAP EPS estimate (3) $5.20 – $5.35

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

GAAP EPS estimate $6.55 – $6.80

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

18% - 20%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue growth, reported 13.0% – 14.5%

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

GAAP EPS estimate $4.25 – $4.60

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue growth, reported 19% – 21%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue growth, reported 4.5% – 8.0%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue growth, reported 16% - 17%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

16% - 18%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue growth, reported 13.0% – 15.0%

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

GAAP EPS $7.90 – $8.15

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

GAAP EPS estimate $5.95 – $6.20

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

GAAP EPS estimate (3) $7.10 – $7.35

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Charles River’s reported revenue growth guidance is expected to increase to 16% to 18% for 2021

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

$4.75 to $4.90

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue growth including WIL Research, reported 19% - 22.5%

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

GAAP EPS estimate $4.65-$4.80

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue growth, reported 1.5% – 4.5%

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

GAAP EPS estimate (2) $7.40 – $8.60

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

GAAP EPS estimate (1) $3.60 - $3.70

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

7.5% - 9.0%

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

GAAP EPS estimate $7.60 – $8.20

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

GAAP EPS $8.70 – $8.95

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

$4.18-$4.33

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue growth, reported 20.5% – 22.5%

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

GAAP EPS estimate $9.20 – $9.45

revised by a later guidancereceipt (opens in a new tab)

Credibility timeline

ABOVE · Feb 11, 2020ABOVE · Feb 11, 2020ABOVE · Feb 17, 2021ABOVE · Feb 17, 2021ABOVE · Feb 16, 2022ABOVE · Feb 16, 2022ABOVE · Feb 22, 2023ABOVE · Feb 22, 2023ABOVE · Feb 14, 2024ABOVE · Feb 14, 2024BELOW · Feb 19, 2025BELOW · Feb 19, 2025
20202025
Timeline as a list
  • Feb 11, 2020ABOVERevenue growth, reported 15.0% - 15.5%
  • Feb 11, 2020ABOVEGAAP EPS estimate $4.65-$4.75
  • Feb 17, 2021ABOVEGAAP EPS estimate $4.70 – $5.00
  • Feb 17, 2021ABOVERevenue growth, reported 7.5% – 9.0%
  • Feb 16, 2022ABOVEGAAP EPS estimate $7.05 – $7.15
  • Feb 16, 2022ABOVERevenue growth, reported 19.5% – 20.5%
  • Feb 22, 2023ABOVERevenue growth, reported 10.0% – 11.0%
  • Feb 22, 2023ABOVEGAAP EPS $7.90 – $8.05
  • Feb 14, 2024ABOVEGAAP EPS estimate $7.30 – $7.50
  • Feb 14, 2024ABOVERevenue growth, reported 2.5% – 3.5%
  • Feb 19, 2025BELOWGAAP EPS estimate $7.90 – $8.40
  • Feb 19, 2025BELOWRevenue growth, reported 1.0% – 4.0%
26 resolved guidance promises · 43 not graded (no comparable reported figure) · resolver resolver-v5 · score score-v1. Every verdict links to its source filing. Full methodology →